First-in-human universal CAR-T therapy trial begins
The dose-finding trial will evaluate the safety and activity of…
The dose-finding trial will evaluate the safety and activity of UniCAR-T-PSMA in up to 16 patients with advanced relapsed/refractory, PSMA-positive solid tumours.